XML Sitemap

This is a XML Sitemap which is supposed to be processed by search engines which follow the XML Sitemap standard like Ask.com, Bing, Google and Yahoo.
It was generated using the WordPress content management system and the Google Sitemap Generator Plugin by Arne Brachhold.
You can find more information about XML sitemaps on sitemaps.org and Google's list of sitemap programs.

URLPriorityChange frequencyLast modified (GMT)
https://www.bigmoleculewatch.com/2017/09/28/fda-draft-guidance-describes-fdas-current-thinking-evaluating-analytical-similarity-biosimilar-products/20%Monthly2018-02-02 14:35
https://www.bigmoleculewatch.com/2017/09/28/amgen-abbvie-settle-adalimumab-bpcia-litigation/20%Monthly2018-01-04 16:08
https://www.bigmoleculewatch.com/2017/09/28/hospira-files-motion-for-jmol/20%Monthly2018-07-25 15:11
https://www.bigmoleculewatch.com/2017/09/27/samsung-bioepis-biosimilar-updates/20%Monthly2018-01-04 16:31
https://www.bigmoleculewatch.com/2017/09/27/jama-obstacles-response/20%Monthly2017-09-27 00:08
https://www.bigmoleculewatch.com/2017/09/25/new-bpcia-litigation-amgen-v-mylan-w-d-pa/20%Monthly2018-07-25 15:16
https://www.bigmoleculewatch.com/2017/09/25/federal-jury-awards-amgen-70m-in-patent-suit-against-hospira/20%Monthly2018-01-04 17:35
https://www.bigmoleculewatch.com/2017/09/22/sandoz-announces-new-data-for-its-adalimumab-biosimilar/20%Monthly2018-01-04 17:57
https://www.bigmoleculewatch.com/2017/09/20/fda-announces-biosimilar-user-fee-act-rates-fy18/20%Monthly2017-09-20 20:16
https://www.bigmoleculewatch.com/2017/09/20/pfizer-sues-jj-alleges-anticompetitive-practices-connection-remicade/20%Monthly2018-06-26 19:15
https://www.bigmoleculewatch.com/2017/09/19/summary-judgment-motion-infringement-immunex-v-sandoz/20%Monthly2018-01-04 18:34
https://www.bigmoleculewatch.com/2017/09/18/chmp-adopts-positive-opinions-on-bis-cyltezo-and-samsung-bioepiss-ontruzant/20%Monthly2018-01-04 18:36
https://www.bigmoleculewatch.com/2017/09/18/sanofi-regeneron-seek-to-assert-inequitable-conduct-in-dupilumab/20%Monthly2018-07-25 15:33
https://www.bigmoleculewatch.com/2017/09/15/recent-ipr-updates/20%Monthly2018-01-04 19:09
https://www.bigmoleculewatch.com/2017/09/15/amgen-v-hospira-rulings-motions-limine/20%Monthly2018-01-04 18:40
https://www.bigmoleculewatch.com/2017/09/15/biosimilars-council-supports-sandozs-preemption-position-federal-circuit-amicus-brief/20%Monthly2018-01-04 18:54
https://www.bigmoleculewatch.com/2017/09/15/goodwin-named-ip-firm-of-the-year-at-2017-lmg-life-sciences-awards/20%Monthly2019-05-03 14:01
https://www.bigmoleculewatch.com/2017/09/14/bi-files-answer-abbvies-complaint-adalimumab-litigation/20%Monthly2018-07-25 15:34
https://www.bigmoleculewatch.com/2017/09/14/fda-approves-amgens-biosimilar-of-avastin/20%Monthly2018-01-04 19:05
https://www.bigmoleculewatch.com/2017/09/13/scheduling-order-entered-in-janssen-v-samsung-bioepis/20%Monthly2018-07-25 15:35
https://www.bigmoleculewatch.com/2017/09/13/amgenallergan-pfizer-present-positive-phase-3-data-two-investigational-trastuzumab-biosimilars/20%Monthly2018-01-04 19:38
https://www.bigmoleculewatch.com/2017/09/12/fda-accepts-applications-rituximab-filgrastim-biosimilar-candidates/20%Monthly2018-01-04 19:30
https://www.bigmoleculewatch.com/2017/09/12/u-s-argues-amgens-state-law-claim-preempted-bpcia-supporting-sandoz/20%Monthly2018-01-04 19:31
https://www.bigmoleculewatch.com/2017/09/12/amgen-v-hospira-litigation-update/20%Monthly2018-07-25 15:35
https://www.bigmoleculewatch.com/2017/09/08/fresenius-kabi-completes-acquisition-merck-kgaas-biosimilars-business/20%Monthly2018-01-04 20:08
https://www.bigmoleculewatch.com/2017/09/05/amgen-v-apotex-federal-circuit-oral-argument-set/20%Monthly2018-01-04 20:13
https://www.bigmoleculewatch.com/2017/09/05/us-fda-delays-approval-biocon-mylans-biosimilar-trastuzumab/20%Monthly2018-01-04 20:11
https://www.bigmoleculewatch.com/2017/09/01/bpcia-litigation-roundup-summer-2017/20%Monthly2018-03-30 20:30
https://www.bigmoleculewatch.com/2017/09/01/coherus-announces-positive-results-chs-1420-humira-biosimilar-candidate/20%Monthly2018-01-04 21:15